Skip to content

N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine

C25H31N5S — CID 152719069

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine
SMILESCN(c1nc2ccc(-c3ccc4nn(C)cc4c3)cc2s1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C25H31N5S/c1-24(2)13-19(14-25(3,4)28-24)30(6)23-26-21-10-8-17(12-22(21)31-23)16-7-9-20-18(11-16)15-29(5)27-20/h7-12,15,19,28H,13-14H2,1-6H3
InChIKeyZVFPXBGDBFBROB-UHFFFAOYSA-N
MW433.63 g/mol
LogP5.60
Rot. Bonds3

About N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine

N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine (PubChem CID 152719069) has the molecular formula C25H31N5S and a molecular weight of 433.63 g/mol. Its IUPAC name is N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine.

Molecular Properties

Compound NameN-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine
PubChem CID152719069
Molecular FormulaC25H31N5S
Molecular Weight433.63 g/mol
Exact Mass433.23
IUPAC NameN-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine
SMILESCN(c1nc2ccc(-c3ccc4nn(C)cc4c3)cc2s1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C25H31N5S/c1-24(2)13-19(14-25(3,4)28-24)30(6)23-26-21-10-8-17(12-22(21)31-23)16-7-9-20-18(11-16)15-29(5)27-20/h7-12,15,19,28H,13-14H2,1-6H3
InChIKeyZVFPXBGDBFBROB-UHFFFAOYSA-N
XLogP5.60
TPSA45.98 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds3
Heavy Atoms31
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500433.63
LogP ≤ 55.60
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine?
The IUPAC name of N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine (CID 152719069) is N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine.
What is the SMILES notation for N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine?
The canonical SMILES for N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine is CN(c1nc2ccc(-c3ccc4nn(C)cc4c3)cc2s1)C1CC(C)(C)NC(C)(C)C1.
What is the InChIKey of N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine?
The InChIKey is ZVFPXBGDBFBROB-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H31N5S/c1-24(2)13-19(14-25(3,4)28-24)30(6)23-26-21-10-8-17(12-22(21)31-23)16-7-9-20-18(11-16)15-29(5)27-20/h7-12,15,19,28H,13-14H2,1-6H3.
What are the key properties of N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine?
N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine has a molecular weight of 433.63 g/mol, XLogP of 5.60, 3 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-methyl-6-(2-methylindazol-5-yl)-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3-benzothiazol-2-amine is sourced from PubChem (CID 152719069), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.